Document is current
Any future updates will be listed below
-
Authors
Strober, Bruce
Soliman, Ahmed M.
Truong, Bang
Patel, Manish B.
Barqawi, Yazan K.
Gisondi, Paolo
-
Funding
Funding for this research was provided by:
AbbVie
- License Information
-
More Information
Article History
Accepted: 9 June 2024
First Online: 27 June 2024
Declarations
:
: AbbVie funded the study. AbbVie participated in the study design, research, interpretation of the data, review, and approval. All authors had access to the relevant data and participated in the drafting, review, and approval of the abstract. No honoraria or payments were made for authorship.
: Bruce Strober has served as a consultant (received honoraria) for AbbVie, Alamar, Almirall, Alumis, Amgen, Arcutis, Arena, Aristea, Asana, Boehringer Ingelheim, Bristol Myers Squibb, Capital One, Connect Biopharma, CorEvitas, Dermavant, Evelo, Immunic, Janssen, Kangpu, LEO, Lilly, Maruho, Meiji Seika, Mindera, Nimbus, Novartis, Pfizer, Protagonist, Regeneron, Sanofi-Genzyme, Sun, UCB, Union, Ventyxbio, and vTv. He has served as a speaker for AbbVie, Arcutis, Dermavant, Incyte, Janssen, Lilly, Regeneron, and Sanofi-Genzyme and as a co-scientific director (consulting fee) and investigator for CorEvitas Psoriasis Registry. He also serves as the editor-in-chief (honorarium) for the <i>Journal of Psoriasis and Psoriatic Arthritis</i>. Paolo Gisondi has been a consultant and/or speaker for AbbVie, Amgen, Almirall, UCB, Sanofi, Eli Lilly, and Novartis. Ahmed M. Soliman, Bang Truong, and Manish B. Patel are full-time employees of AbbVie Inc. and may hold AbbVie stock or stock options or patents. Yazan K. Barqawi is a former full-time employee of AbbVie Inc. and may hold AbbVie stock or stock options.
: This analysis used a de-identified administrative claims database and thus did not require institutional review board approval.
: Not applicable.
: Not applicable.
: Datasets used in this analysis are available from the corresponding author upon reasonable request.
: All analyses were conducted using the Instant Health Data platform (Panalgo, Boston, MA, USA). The code is available upon request.
: All authors contributed to the interpretation of data and were involved in the drafting and revising of the manuscript. AMS and BT made substantial contributions to the study conception and design and acquisition of data. YKB contributed to the study design and conception. BT contributed to the data analysis.
